SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: QuietWon who wrote (206)1/11/1999 7:38:00 PM
From: JEB  Read Replies (1) | Respond to of 2515
 
Phase III on C225 should be wrapping up soon. IMCL has been in phase III on C225 for several months. Also, the BEC2 Cancer vaccine is in phase III. Just not as long as C225. This company has a lot of appreciation coming soon.



To: QuietWon who wrote (206)1/12/1999 12:38:00 AM
From: JEB  Read Replies (2) | Respond to of 2515
 
QW,

I'm sorry, I was wrong on my last post to you. The C225 proposals are to go to FDA for phase III approval anytime now. The BEC2 is in phase III trials for lung cancer but I have since found that it is being used for patients this year on Kaposi's Sarcoma:

imclone.com

Also, they have been able to isolate vascular stem cells and are studying therapy for repairing diseased or damaged blood vessels:

go2net.newsalert.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News